Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
K
Knight Therapeutics Inc
F:04K
Knight Therapeutics Inc
F:04K
Price:
6.7
EUR
1.52%
Market Closed
Market Cap:
€679.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
K
|
Knight Therapeutics Inc
F:04K
|
CA |
|
R
|
Rovsing A/S
F:RVY
|
DK |
|
G
|
GiantStep Inc
KOSDAQ:289220
|
KR |
|
My Size Inc
F:2YJ
|
IL |
|
Focus Universal Inc
NASDAQ:FCUV
|
US |
|
Celldex Therapeutics Inc
F:TCE2
|
US |
|
O
|
Oracle Corp Japan
SWB:OCJ
|
JP |
|
iEntertainment Network Inc
OTC:IENT
|
US |
|
Bandwidth Inc
F:5XB
|
US |
|
Alantra Partners SA
F:DNY
|
ES |
|
Z
|
Zeon Corp
F:NZE
|
JP |
Wall St Price Targets
04K Price Forecast
Based on 10 analysts
Based on 10 analysts
-43% Downside
from
€6.7
today
Knight Therapeutics Inc (04K)’s 12-month stock price forecast through October 2027 has a consensus target of €3.81, implying 43% downside. The forecast is based on price targets from 10 Wall Street analysts.
Knight Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 04K's stock price target?
Price Target
3.81
EUR
3.81
EUR
According to Wall Street analysts, the average 1-year price target for 04K is 3.81 EUR with a low forecast of 3.71 EUR and a high forecast of 4.28 EUR.
What is the Revenue forecast for Knight Therapeutics Inc?
Projected CAGR
7%
7%
Over the last 10 years, the compound annual growth rate for Revenue has been 84%. The projected CAGR for the next 5 years is 7%.
What is the Gross Profit forecast for Knight Therapeutics Inc?
Projected CAGR
8%
8%
Over the last 10 years, the compound annual growth rate for Gross Profit has been 79%. The projected CAGR for the next 5 years is 8%.
What is the Operating Income forecast for Knight Therapeutics Inc?
Projected CAGR
59%
59%
The compound annual growth rate for Operating Income over the next 5 years is 59%.